Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease
about
Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PREDIGT scoreThe Monoamine Brainstem Reticular Formation as a Paradigm for Re-Defining Various Phenotypes of Parkinson's Disease Owing Genetic and Anatomical Specificity.Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation CarriersNonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 geneNeurite Aggregation and Calcium Dysfunction in iPSC-Derived Sensory Neurons with Parkinson's Disease-Related LRRK2 G2019S Mutation.REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers.Drosophila Mutant Model of Parkinson's Disease Revealed an Unexpected Olfactory Performance: Morphofunctional Evidences.The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies.Clinical Features of LRRK2 Carriers with Parkinson's Disease.Olfactory disturbances in ageing with and without dementia: towards new diagnostic tools.Nigral and striatal connectivity alterations in asymptomatic LRRK2 mutation carriers: A magnetic resonance imaging study.Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease.Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in miceProspective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-associated Parkinson disease.Premotor Diagnosis of Parkinson's Disease.DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease.In Vitro Modeling of Leucine-Rich Repeat Kinase 2 (LRRK2) G2019S-Mediated Parkinson's Disease Pathology.Clinical Heterogeneity Among Variants in Parkinson's Disease: A Meta-Analysis
P2860
Q29048624-3441BEB9-88A9-4E52-9E31-82B141B9FFE3Q30357944-1AE2EB2D-DA4E-4DEC-A7F4-9EB4A224FEE9Q35692655-6E92F26B-84EA-43E5-A6F4-10DFA16E063CQ35772821-25C80ED9-73A3-4D6B-9713-0D020471C8ADQ36379938-67293300-C0A8-4EED-932F-72941732BF28Q36470291-3F479504-653A-4212-92FD-7690E76D363AQ37246534-2EF6D16F-E3CB-478A-8186-32A9BF1D6048Q38859352-0B836194-4CFE-4009-8130-54E59A447E50Q39206423-C65E48D3-6E5C-4694-B6A4-145EECCE898CQ39251022-E627E964-E164-4558-8DEF-D0525ABC8148Q39366467-824F46C7-84B2-430C-BB2B-E8DBC269483CQ39841718-25DAF225-571A-45B4-9B02-890BC778045DQ42268862-C9E2B942-2659-4C1C-8B05-55667059856CQ44060284-EA72FC43-2E74-418E-8C86-9422828E16E1Q47701138-9F3855E5-8211-401C-8831-2E1E6A1B58DBQ47907932-2CDE3CA7-7A50-4E6E-997C-97E3FD3E8422Q54984575-7C1BFAD0-AF61-4C44-8CA0-E2A1B3FCF860Q57072461-21DF7B0E-903D-458F-8A99-AEE4C56E6EDE
P2860
Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease
@ast
Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease
@en
Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease
@nl
type
label
Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease
@ast
Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease
@en
Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease
@nl
altLabel
Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease
@en
prefLabel
Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease
@ast
Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease
@en
Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease
@nl
P2860
P50
P1433
P1476
Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease
@en
P2860
P304
P356
10.1371/JOURNAL.PONE.0108982
P4011
5bc62e2229075e2b6e2c87b6c32235047d947369
P407
P50
P577
2014-10-17T00:00:00Z